Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Measuring Oncological Value of Exercise and Statin [Phase 3]
Phase 3 clinical trial assessing the oncological value of combining exercise with a statin across prostate, breast, kidney, and ovarian canc…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Surgery for Relapsed Ovarian Cancer in Precision [Phase 1, Phase 2]
A precision medicine-guided surgical approach for relapsed ovarian, fallopian tube, and primary peritoneal cancers is being explored in Phas…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Ovarian Cancer Radiomics Approach in CT Led Evaluation
This clinical trial update describes a radiomics-based CT imaging study for evaluating ovarian cancer, sponsored by Imperial College Healthc…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
A study to develop and validate a risk prediction model for ovarian cancer among relatives of ovarian cancer probands. The research consider…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial [Phase 2]
A Phase 2 pilot trial at UC Irvine is evaluating repurposed riluzole for cancer-related cognitive impairment across multiple cancer types, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors [NA]
An ongoing study is investigating a combined program of supervised exercise and nutritional counseling for ovarian cancer patients on frontl…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
A Yonsei University-led clinical trial investigates diagnosing multiple cancers and monitoring minimal residual disease using blood-based, h…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: HS-10502 Combination Treatment in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial update for HS-10502 in patients with advanced solid tumors, including recurrent ovarian cancer and HER2-negative br…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer [NA]
This clinical trial update reports a planned study from Seoul National University Hospital evaluating proactive immune tolerance induction d…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer [Phase 3]
Phase 3 trial updating a comparison of Fluzoparib plus Bevacizumab with a dietary intervention versus Fluzoparib monotherapy as first-line m…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
This Clinical Trials update shows a study evaluating minimally invasive interval debulking surgery for advanced ovarian cancer; the trial st…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Ultrasound Training Program for Gynecologic Cancer Staging in Residents [NA]
An educational clinical trial update describes an ultrasound training program for gynecologic cancer staging intended for residents, coverin…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses [NA]
This clinical trial update reports on an ongoing study (NCT06473766) sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCC…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
This McGill University–sponsored clinical trial is evaluating a genomics-based approach for early diagnosis of ovarian and endometrial cance…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
A cohort study at Peking University Third Hospital evaluating hereditary ovarian cancer risk prediction models and pathogenesis. It is curre…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ASk Questions in GYnecologic Oncology (ASQ-GYO) [NA]
Clinical trial ASk Questions in Gynecologic Oncology (ASQ-GYO), sponsored by Ira Winer, is currently recruiting and covers ovarian and endom…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating ONC-201 in combination with weekly paclitaxel for platinum-refractory or resistant ovarian cancer; current…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers [NA]
This clinical trial update describes an ongoing study led by McGill University focused on early detection of endometrial and ovarian cancer …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer [Phase 2]
Phase 2 trial RESOLVE is evaluating abemaciclib plus letrozole, with optional metformin, zotatifin, or gedatolisib, in endometrial cancer an…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) [Phase 2]
A three-arm Phase II clinical trial evaluates dostarlimab alone or with bevacizumab versus nonplatinum chemotherapy in recurrent gynecologic…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
A completed real-world observational study evaluating the safety and adverse events of olaparib in Chinese patients with ovarian cancer.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
This clinical trial update describes cascade genetic testing in families with newly diagnosed hereditary breast and ovarian cancer syndrome.…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer [NA]
This clinical trial update notes ongoing recruitment for a study of secondary interval cytoreductive surgery in platinum-sensitive recurrent…